EphB4 controls blood vascular morphogenesis during postnatal angiogenesis

Guidance molecules have attracted interest by demonstration that they regulate patterning of the blood vascular system during development. However, their significance during postnatal angiogenesis has remained unknown. Here, we demonstrate that endothelial cells of human malignant brain tumors also express guidance molecules, such as EphB4 and its ligand ephrinB2. To study their function, EphB4 variants were overexpressed in blood vessels of tumor xenografts. Our studies revealed that EphB4 acts as a negative regulator of blood vessel branching and vascular network formation, switching the vascularization program from sprouting angiogenesis to circumferential vessel growth. In parallel, EphB4 reduces the permeability of the tumor vascular system via activation of the angiopoietin‐1/Tie2 system at the endothelium/pericyte interface. Furthermore, overexpression of EphB4 variants in blood vessels during (i) vascularization of non‐neoplastic cell grafts and (ii) retinal vascularization revealed that these functions of EphB4 apply to postnatal, non‐neoplastic angiogenesis in general. This implies that both neoplastic and non‐neoplastic vascularization is driven not only by a vascular initiation program but also by a vascular patterning program mediated by guidance molecules.

[1]  R. Klein,et al.  Eph receptors and ephrins: effectors of morphogenesis. , 1999, Development.

[2]  Li Yuan,et al.  The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system , 2004, Nature.

[3]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[4]  T. Suda,et al.  Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. , 2002, Blood.

[5]  D. Anderson,et al.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.

[6]  Peter Vajkoczy,et al.  Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  J. Tonn,et al.  Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. , 2002, The Journal of clinical investigation.

[8]  E. Pasquale,et al.  Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.

[9]  R. Adams.  Vascular patterning by Eph receptor tyrosine kinases and ephrins. , 2002, Seminars in cell & developmental biology.

[10]  G Garcia-Cardena,et al.  Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. , 2001, Developmental biology.

[11]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[12]  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Souque,et al.  Choosing highly specific primers for the polymerase chain reaction using the octomer frequency disparity method: application to Chlamydia trachomatis. , 1996, Gene.

[14]  R. Klein,et al.  Eph receptors and ephrin ligands. essential mediators of vascular development. , 2000, Trends in cardiovascular medicine.

[15]  H. Augustin,et al.  Inhibition of tumor growth and angiogenesis by soluble EphB4. , 2004, Neoplasia.

[16]  A. Brändli,et al.  The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. , 2000, Development.

[17]  S A Tschanz,et al.  Intussusceptive angiogenesis: its role in embryonic vascular network formation. , 2000, Circulation research.

[18]  Chad A. Cowan,et al.  Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. , 2004, Developmental biology.

[19]  F. Diella,et al.  The Cytoplasmic Domain of the Ligand EphrinB2 Is Required for Vascular Morphogenesis but Not Cranial Neural Crest Migration , 2001, Cell.

[20]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[21]  E. Pasquale,et al.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Lackmann,et al.  Signals from Eph and Ephrin Proteins: A Developmental Tool Kit , 2001, Science's STKE.

[23]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[24]  A. Tulpule,et al.  Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. , 2005, Blood.

[25]  X. Q. Zhang,et al.  Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells. , 2001, Blood.

[26]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[27]  David G. Wilkinson,et al.  Multiple roles of eph receptors and ephrins in neural development , 2001, Nature Reviews Neuroscience.

[28]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[29]  M. Menger,et al.  Characterization of Angiogenesis and Microcirculation of High–Grade Glioma: An Intravital Multifluorescence Microscopic Approach in the Athymic Nude Mouse , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  M. Thibon,et al.  K-tuple frequency in the human genome and polymerase chain reaction. , 1991, Nucleic acids research.

[31]  F. Pontén,et al.  Zinc-Based Fixative Improves Preservation of Genomic DNA and Proteins in Histoprocessing of Human Tissues , 2003, Laboratory Investigation.